Evidence map›Paper›PMID 36251532›Full record

ArticleESC heart failure2023

Exergaming in patients with a left ventricular assist device: a feasibility study.

Yoav Hammer, Aviv A Shaul, Binyamin Ben-Avraham, Osnat Itzhaki Ben Zadok, Yaron D Barac, Victor Rubchevsky, Vicky Yaari, Ema Gutrov, Anna Strömberg, Leonie Klompstra and 2 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Yoav HammerDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Aviv A ShaulDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Binyamin Ben-AvrahamDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Osnat Itzhaki Ben ZadokDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Yaron D BaracSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Victor RubchevskySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Vicky YaariDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Ema GutrovDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Anna StrömbergDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Leonie KlompstraDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Tiny JaarsmaDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Tuvia Ben-GalDepartment of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
Rabin Medical Center · ILTel Aviv University · ILLinköping University · SE

Funding

Swedish National Science Council 2016-01390
6 · The paper itself

Abstract

aimsExercise games (exergames) have been recently proposed as a mode of facilitating physical activity in patients with chronic diseases. Although patients supported with left ventricular assist devices (LVADs) benefit from physical activity, specific LVAD-related issues hinder their ability to exercise properly. The objective of this study was to assess the feasibility and safety of exergaming in LVAD-supported patients. METHODS AND

resultsEleven LVAD-supported patients were enrolled in a 4 week exergaming programme using Nintendo Wii console with five sport games. Patients were instructed to play for 30 min a day, 5 days a week. Data on exercise capacity and exergaming were collected by using the 6 min walk test (6MWT) and a daily self-report diary, respectively. Feasibility of using the console and its safety was assessed by a semi-structured patient interview. Quality of life was assessed by the Minnesota Living with Heart failure Questionnaire (MLHFQ) and the Cantril's Ladder of Life. Safety was assessed by patient's report in interview and diary. The study group consisted of 10 male patients and 1 female patient, mean age of 67 ± 7 years, of whom 10 were supported with the HeartMate 3 LVAD for a median of 10 (interquartile range 3, 21) months. Baseline exercise capacity assessed by the 6MWT ranged from 240 to 570 m (mean 448 ± 112). After 4 weeks of exergaming, 6MWT distance increased from a mean of 448 ± 112 (evaluated in six patients) to 472 ± 113 m (P = 0.023). Patients' Cantril's Ladder of Life score improved numerically from an average of 6.13 to 7.67, as did their MLHFQ score from 45.9 ± 27 to 38.7 ± 18, with higher and lower scores, respectively, reflecting higher quality of life. No specific LVAD-related safety issues regarding exergaming were reported.

conclusionsExergaming was found to be a safe and feasible mode for encouraging physical activity in LVAD-supported patients and carries a potential for improving exercise capacity and quality of life in these patients. Larger scale studies are warranted to further investigate the effect of exergaming in this patient population.

Indexed as

Heart-Assist DevicesHeart FailureExergamingFeasibility StudiesFemaleHumansMaleQuality of LifeExerciseExergamesHeart failureLeft ventricular assist deviceSix-minute walk test

Identifiers

PMID36251532
PMCPMC9871679
OpenAlexW4306412222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.